Healthcare

By

Bret Jensen

 | May 15, 2017 | 1:00 PM EDT
Three names show how fast biotechs can become oversold when the market acts in knee-jerk fashion.
RMPIA
By

Bret Jensen

 | May 12, 2017 | 11:30 AM EDT
These names are now undervalued, despite solid results and good fundamentals.
By

Robert Moreno

 | May 8, 2017 | 1:00 PM EDT
The price momentum and money flow indicators of the drug maker are in positive alignment.
By

Bret Jensen

 | May 5, 2017 | 1:00 PM EDT
Readers have asked about these three small biotechs that have seen their share prices droop lately.
By

Robert Lang

 | May 5, 2017 | 10:00 AM EDT
Buyers are coming in and prices are moving up.
By

James "Rev Shark" DePorre

 | May 4, 2017 | 12:57 PM EDT
This corrective action has me feeling optimistic about some new opportunities.
RMPIA
By

Bret Jensen

 | May 3, 2017 | 11:40 AM EDT
How did Celgene, AbbVie and Gilead fare last quarter?
RMPIA
By

James "Rev Shark" DePorre

 | May 2, 2017 | 10:41 AM EDT
Without strength in the big-cap leaders, this market is tough to trade.
By

Bruce Kamich

 | May 1, 2017 | 2:08 PM EDT
Prices are extended on the downside.
RMPIA
By

Robert Lang

 | May 1, 2017 | 11:30 AM EDT
Clues in the chart point to higher prices to come.
Under Armour's founder Kevin Plank has never been one to sound weak in a public setting. P...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.